Aligos Therapeutics Inc (ALGS)
1.34
+0.02 (+1.52%)
USD |
NASDAQ |
Mar 20, 11:14
Aligos Therapeutics Profit Margin (Quarterly): -618.8% for Dec. 31, 2022
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -618.8% |
| September 30, 2022 | -453.5% |
| June 30, 2022 | -539.5% |
| March 31, 2022 | -1.39K% |
| Date | Value |
|---|---|
| December 31, 2021 | -10.28K% |
| September 30, 2021 | -2.16K% |
| June 30, 2021 | -1.93K% |
| March 31, 2021 | -3.04K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-10.28K%
Minimum
Dec 2021
-453.5%
Maximum
Sep 2022
-2.55K%
Average
-1.66K%
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 21.81% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -30.40K% |
| NovaBay Pharmaceuticals Inc | -3.55% |
| Protalix BioTherapeutics Inc | -43.40% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -68.55% |
| Return on Assets | -51.14% |
| Return on Invested Capital | -68.55% |
| Operating Margin (Quarterly) | -641.3% |
| Return on Net Operating Assets | -687.9% |